1. Medtech Insight
  2. >>Device Area
  3. >>Diabetic Care

Podcast: FDA Panel Overwhelmingly Votes For Dexcom CGM to Replace Finger Sticks

The US FDA's Clinical Chemistry and Clinical Toxicology Devices Panel voted eight to two to recommend Dexcom's G5 Continuous Glucose Monitor to replace finger-stick testing in diabetic patients over the age of two. Also, a post-panel podcast chat with Dexcom's Steve Pacelli.

Event

The conference room erupted in applause July 21 as an FDA advisory panel overwhelmingly voted to recommend Dexcom's G5 Continuous Glucose Monitor system as a replacement, rather than simply an adjunct, to conventional finger-stick testing for diabetics. In an eight to two vote the Clinical Chemistry and Clinical Toxicology Devices Panel voted the benefits of the expanded indication outweigh the risks.

Current labeling for CGMs made by the two US manufacturers of CGMs, Dexcom and Medtronic, includes a requirement for a confirmatory

More from Diabetic Care

More from Device Area

Digital Health And AI Tools Advance Cardiac Event Prediction, SCAI 2025 Data Show

 
• By Shubham Singh

Out-of-hospital cardiac arrest remains one of the most challenging and resource-intensive emergencies in cardiovascular care. At SCAI 2025, clinicians presented a novel algorithm that improved triage decisions and reduced unnecessary interventions.

SpotitEarly Raised $20.3M In New Funding To Bring AI- And Dog-Sniffing-Powered Early Cancer Detection Test To US

 
• By Marion Webb

Israeli-based SpotitEarly hopes to bring an early cancer-detection test, which uses dogs’ noses to detect compounds in exhaled breath and AI analysis, to US homes in 2026.

Thousands Of Cardiac Digital Twins Reveal Novel Connections With Mental Health

 
• By Natasha Barrow

King’s College London, Imperial College London and The Alan Turing Institute constructed cardiac digital twins at scale, creating over 3,400, in a new study using UK Biobank data published in Nature Cardiovascular Research on 16 May.